Every Form 4 that CACI INTERNATIONAL CLA (CACI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CACI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CACI filings page.
CACI International (CACI): Director Lisa Disbrow reported the vesting and settlement of 83 restricted stock units into CACI common stock on 10/12/2025 (transaction code M). Following this transaction, she beneficially owns 1,934 shares, held directly.
The RSUs were part of a 331‑unit grant made on October 17, 2024, vesting in tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International (CACI): Director Susan M. Gordon reported the settlement of restricted stock units into common shares. On 10/12/2025, 83 RSUs vested and converted into 83 shares of CACI common stock (transaction code M), consistent with a previously disclosed grant.
The RSUs were part of a 331-unit award granted on October 17, 2024, vesting in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025. Following this vesting, Ms. Gordon directly owns 2,737 CACI shares.
This filing reflects routine equity compensation vesting for a director and does not indicate an open-market purchase or sale.
Jeffrey D. MacLauchlan, Chief Financial Officer of CACI International Inc. (CACI), reported multiple equity awards and vesting-related transactions dated 10/01/2025. The filing shows a combination of restricted stock unit (RSU) vesting events and new grants: a total of 4,981 shares added to beneficial ownership from vested and granted units and a separate grant of 1,942 performance restricted stock units (PRSU) that will vest based on a three-year performance measure. Several previously granted RSUs from 2022–2024 partially vested according to a one-third-per-year schedule, and some PRSUs from earlier grants vested or expired per their terms. Following the reported transactions, Mr. MacLauchlan beneficially owns between 3,321 and 4,331 shares on various lines immediately after specific reported sales, with differing totals shown across lines due to multiple separate transactions and vesting events.
John S. Mengucci, President & CEO and director of CACI International, Inc. (CACI), reported multiple stock-based transactions on 10/01/2025 on Form 4. The filing shows a mix of acquisitions and dispositions of common stock and the vesting/granting of restricted stock units (RSUs) and performance RSUs (PRSUs). Following the transactions, Mr. Mengucci beneficially owned between 103,884 and 128,827 shares across the reported lines depending on each transaction line's cumulative totals. The report records vested and newly granted awards: 12,618 PRSUs and 12,617 RSUs granted on 10/01/2025, plus earlier grants from 2022–2024 with specified vesting schedules. Several disposition entries list a price of $515.16 per share. The filing is a routine insider report documenting compensation-related equity grants and related share movements.
DeEtte Gray, President, US Operations of CACI, reported transactions dated 10/01/2025 on a Form 4. The filing shows multiple restricted stock unit and performance restricted stock unit grants and vesting events: prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are described, and new grants on 10/01/2025 include 2,233 performance RSUs and 2,232 restricted stock units. The Form 4 also records a series of non-derivative transactions on the same date including dispositions executed at a reported price of $515.16. The tables list changing beneficial ownership totals after each reported event for CACI common stock. The signature date on the form is 10/03/2025.
Tracy Weir, Chief Executive Officer, UK of CACI International Inc. (CACI), reported multiple transactions dated 10/01/2025. The Form 4 shows grants of 291 restricted stock units and 292 performance restricted stock units (total 583 units) granted on that date; the PRSUs vest on the third anniversary subject to a three‑year performance measure and the RSUs vest one‑third per year over three years. The filing also records multiple dispositions totaling 413 shares sold at $515.16 per share, and changes in beneficial ownership levels reported after each transaction. The report is a routine insider filing documenting equity awards and share sales by an executive.
J. William Koegel Jr., EVP & General Counsel of CACI (CACI) reported multiple transactions dated 10/01/2025. The filing shows the vesting/acquisition of 4,442 common shares through restricted stock units and performance restricted stock units and the grant of 971 additional restricted stock units plus 971 performance restricted stock units. Concurrently, the report discloses dispositions of 2,101 common shares at $515.16 per share. After these transactions, Mr. Koegel beneficially owned 27,931 shares of CACI common stock, held directly.
Eric Blazer, Senior Vice President, Corporate Controller & Chief Accounting Officer of CACI International, Inc. (CACI), reported equity awards and transactions on a Form 4. On 10/01/2025 he received 194 restricted stock units (RSUs) and 195 performance restricted stock units (PRSUs); the PRSUs vest on the third anniversary based on a three‑year performance measure. The report also records earlier entries: a 65-share grant coded as M and an earlier 198 RSU grant dated 10/01/2024 that vests one‑third per year for three years. Following the transactions reported, Mr. Blazer beneficially owns reported totals of 132, 112, and derivative holdings of 194, 195, and 133 shares in the classes listed. The Form is signed 10/03/2025.